Reflex control of circulation and angiotensin converting enzyme inhibition in man
- PMID: 3066877
Reflex control of circulation and angiotensin converting enzyme inhibition in man
Abstract
Removal of the facilitating effect of angiotensin II on sympathetic cardiovascular influences may enhance the antihypertensive effect of angiotensin converting enzyme (ACE) inhibitors but may also disturb reflexes involved in blood pressure homeostasis. To test this hypothesis in essential hypertensive subjects, the forearm vasomotor response to cardiopulmonary receptor deactivation (lower body negative pressure) was studied before and after acute or prolonged administration of captopril at doses capable of lowering blood pressure and blocking the formation of angiotensin II. After either acute or prolonged captopril administration there was less response (i.e. forearm vasoconstriction) than in the no-drug state. However, in the same subjects, another reflex response to cardiopulmonary receptor deactivation, the increase in plasma renin activity, was not blunted by the drug. Furthermore, the other major reflex responsible for blood pressure homeostasis, the arterial baroreflex, was left unchanged or was even favoured by administration of clinically effective doses of captopril. This finding applied to both the heart rate and the blood pressure modulating ability of the reflex (vasoactive drug and neck chamber techniques, respectively). Thus, reflex control of circulation may be adversely affected by ACE inhibition. However, this does not include all reflex targets and at least one major reflex is preserved following this pharmacological intervention. This may explain why our patients showed no orthostatic hypotension during chronic treatment with ACE inhibitors.
Similar articles
-
Acute and chronic converting enzyme inhibition reduces the vasomotor response to reflex sympathetic activation in man.J Hypertens Suppl. 1985 Dec;3(3):S259-62. J Hypertens Suppl. 1985. PMID: 2856713
-
Investigation of reflexes from volume and baroreceptors during converting-enzyme inhibition in humans.Am Heart J. 1989 Mar;117(3):740-5. doi: 10.1016/0002-8703(89)90764-3. Am Heart J. 1989. PMID: 2645757
-
Alterations in plasma noradrenaline in response to reflex modulation of sympathetic vasoconstrictor tone to skeletal muscles.J Hypertens Suppl. 1984 Dec;2(3):S131-3. J Hypertens Suppl. 1984. PMID: 6599659
-
Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?Clin Ther. 2007 Sep;29(9):1803-24. doi: 10.1016/j.clinthera.2007.09.019. Clin Ther. 2007. PMID: 18035185 Review.
-
Angiotensin-converting enzyme inhibition in patients with essential hypertension.Clin Physiol Biochem. 1990;8 Suppl 1:16-24. Clin Physiol Biochem. 1990. PMID: 2257720 Review.
Cited by
-
Importance of the renin-angiotensin-aldosterone system (RAS) in the physiology and pathology of hypertension. An overview.Drugs. 1990;39 Suppl 2:1-8. doi: 10.2165/00003495-199000392-00002. Drugs. 1990. PMID: 2188822 Review.
-
QT dispersion in patients with chronic heart failure: beta blockers are associated with a reduction in QT dispersion.Heart. 1999 Mar;81(3):297-302. doi: 10.1136/hrt.81.3.297. Heart. 1999. PMID: 10026356 Free PMC article.
-
A facilitatory effect of anti-angiotensin drugs on vagal bradycardia in the pithed rat and guinea-pig.Br J Pharmacol. 1993 Sep;110(1):289-96. doi: 10.1111/j.1476-5381.1993.tb13807.x. Br J Pharmacol. 1993. PMID: 8220890 Free PMC article.
-
Effects of the angiotensin type I receptor antagonist, losartan, on systemic and regional vascular responses to lower body negative pressure in healthy volunteers.Br J Clin Pharmacol. 1995 Nov;40(5):431-8. Br J Clin Pharmacol. 1995. PMID: 8703646 Free PMC article. Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous